Latest News

CubeSmart recently reported fourth-quarter and full-year 2025 results showing higher revenue, as sales rose to US$240.93 million for the quarter and US$956.65 million for the year, but net income and earnings per share declined compared with 2024. Alongside affirming a US$0.53 quarterly dividend for April 2026, management issued 2026 guidance that points to flat to slightly negative same-store revenue and net operating income growth, highlighting a more cautious near-term outlook for the...

Zscaler (NasdaqGS:ZS) and Bharti Airtel have launched an India focused AI & Cyber Threat Research Center. The new center is designed to support national cyber resilience and research on AI driven threat detection. The initiative aims to build cybersecurity talent in India and deepen cooperation between public and private sector stakeholders. Zscaler, traded on the NasdaqGS under the ticker ZS, focuses on cloud delivered security for enterprises that are shifting applications and data to the...

Air New Zealand (NZSE:AIR) has just posted its H1 2026 scorecard, with total revenue for H2 2025 of NZ$3.4b and basic EPS of NZ$0.0061, while the latest trailing 12 months show NZ$6.8b of revenue and a small net loss translating to basic EPS of NZ$0.0036. Over recent halves, the airline has seen revenue move from NZ$3.3b in H2 2024 to NZ$3.4b in H1 2025 and NZ$3.4b in H2 2025, with basic EPS ranging from NZ$0.0051 in H2 2024 to NZ$0.031 in H1 2025 and NZ$0.0061 in H2 2025. With the shares...

Treasury Wine Estates (ASX:TWE) has drawn fresh attention after reporting a half year net loss of A$649.4 million and suspending its interim dividend for the period ended 31 December 2025. See our latest analysis for Treasury Wine Estates. The results release and dividend suspension appear to have weighed on sentiment, with a 30 day share price return of 13.85% decline and a 1 year total shareholder return of 56.56% loss pointing to fading momentum. If this update has you rethinking where you...

Recent reports that Deutsche Bank (XTRA:DBK) is integrating Ripple's blockchain technology into cross border payments, foreign exchange workflows, and digital asset custody give investors a fresh angle on the bank's digital transformation story. See our latest analysis for Deutsche Bank. The reported Ripple integration comes as Deutsche Bank's share price, now at €31.04, shows mixed momentum, with a 1-day share price return of 1.44% and a 1-year total shareholder return of 55.63% following...

nLIGHT (NasdaqGS:LASR) plans to exit the cutting and welding markets as it reshapes its business focus. The company has raised over $190 million to invest in manufacturing capacity, new product development, and potential M&A. nLIGHT reports strong performance from its aerospace and defense segment as it reallocates resources toward this area. nLIGHT, trading under NasdaqGS:LASR, is drawing attention after a sharp share price move. The stock is at $62.95, up 13.1% over the past week and...

If you are wondering whether Iovance Biotherapeutics at around US$3.79 is a bargain or a value trap, you are not alone. This article will walk through what the current price could mean for you. The stock has recently moved sharply, with a 33% return over the last 7 days, 27.2% over the last 30 days, and 50.4% year to date, even though the 1 year, 3 year and 5 year returns remain negative. These swings have come as investors react to ongoing developments around Iovance Biotherapeutics and its...

Why Lithia Motors stock is drawing attention now Lithia Motors (LAD) has been on many investors’ radar after recent share performance, with the stock showing a negative move over the month and past 3 months, prompting closer scrutiny of its current valuation. See our latest analysis for Lithia Motors. At a share price of $281.46, Lithia Motors has seen a 1 day share price return of 0.69%, set against a weaker 30 day share price return of 13.97% and a 1 year total shareholder return of 17.7%...

Darling Ingredients recently reported quarterly revenues that came in well above analyst expectations, with management highlighting strong operational execution, EBITDA growth and improved gross margins despite industry headwinds. The company also disclosed a planned 2026 retirement of long-time lead director Gary Mize and the immediate addition of former Cargill executive Robert Aspell to the board and Audit Committee, potentially sharpening oversight around global agriculture exposure and...

SentinelOne (NYSE:S) has launched a next generation identity security platform focused on protecting both human users and AI agent accounts. The new offering shifts from traditional authentication checks to continuous, behavior based validation and runtime authorization withdrawal. The move targets rising identity centric threats as enterprises adopt more automation and AI driven workflows. SentinelOne enters this launch with shares at $13.48 and a mixed recent track record, including a...

In recent days, On Holding attracted heightened attention as UBS and Zacks reiterated very positive views ahead of the company’s now-past 3 March 2026 earnings release, citing strong consumer momentum, solid revenue growth and earlier earnings surprises. This cluster of upbeat analyst commentary has sharpened focus on how On’s recent operational performance may be reshaping expectations for its long-term growth profile and profitability. Now, we’ll examine how this rising analyst optimism...

In recent weeks, ServiceTitan was highlighted by Wall Street analysts as one of the best beaten down technology names, with Morgan Stanley upgrading it to Overweight and naming it a sector top pick while institutional investors such as Artisan increased their holdings following earlier software weakness. These moves underscore growing institutional and analyst confidence in ServiceTitan’s vertical software model for trades and its potential to expand across additional end markets and product...

Mesoblast Limited recently reported half-year 2025 results, with revenue rising to US$51.34 million and net loss and loss per share both narrowing, and subsequently issued fiscal 2026 guidance calling for US$110 million to US$120 million in Ryoncil net revenue. This combination of sharply higher reported revenue and the first detailed full-year outlook for Ryoncil offers investors a clearer view of Mesoblast’s early commercial trajectory and cost profile. We’ll now examine how Mesoblast’s...

This article is designed to help you assess whether National Energy Services Reunited still represents good value after its recent share price run, or whether the excitement has moved ahead of the company’s fundamentals. The stock last closed at US$25.14, with returns of 3.9% over 7 days, 26.0% over 30 days, 59.2% year to date and 207.7% over the past year, as well as 278.6% over 3 years and 95.0% over 5 years. These moves have put the company on more investors' radar, and they have been...

Amneal Pharmaceuticals recently issued 2026 earnings guidance, projecting net revenue between US$3.05 billion and US$3.15 billion, alongside heightened attention around its latest quarterly earnings release. This new guidance gives investors a clearer view of management’s expectations for the scale of Amneal’s business as it expands across generics, injectables, biosimilars, and specialty products. We’ll now examine how Amneal’s US$3.05–3.15 billion 2026 revenue outlook may influence the...

Sunrun Inc. has reported its fourth-quarter and full-year 2025 results, with sales reaching US$466.49 million for the quarter and US$1.82 billion for the year, revenue of US$1.16 billion for the quarter and US$2.96 billion for the year, and a swing from a multi‑billion‑dollar net loss in 2024 to net income of US$103.57 million for the quarter and US$449.95 million for 2025. Beyond the earnings beat, Sunrun’s growing battery footprint, now more than 217,000 residential systems and a 71%...

If you are wondering whether First Financial Bankshares is reasonably priced or you might be overpaying at US$33.45, you are asking the right question before making any decisions. The share price has moved 1.1% over the last week, 5.1% over the past month, and 11.4% year to date, while the 1 year return sits at an 8.2% decline and the 3 and 5 year returns are 0.5% and 18.0% declines respectively. Recent coverage has focused on broad sector trends and regional bank conditions, which helps...

This article is designed to help you assess whether Innodata's share price aligns with its underlying worth, or if sentiment has run ahead of fundamentals. Innodata last closed at US$47.58, with a 4.3% return over the past week, an 18.9% decline over the past month, a 10.2% decline year to date, a 9.6% decline over 1 year and a very large 3 year and 5 year return that is more than 7x. Recent headlines around Innodata have focused on its role in data engineering and AI related services,...

Excellon Resources (TSXV:EXN) has put the Mallay silver lead zinc mine in Peru back in focus after releasing its first independent Mineral Resource Estimate, a key input for potential restart planning. See our latest analysis for Excellon Resources. The new Mallay resource update lands after a very large 1 year total shareholder return of about 4x, supported by a 107.87% 90 day share price return. However, 5 year total shareholder return remains deeply negative, suggesting momentum has picked...

If you are wondering whether Sysmex shares are now priced attractively or still have further to fall, this article walks through what the current share price might be implying about the company's value. The stock last closed at ¥1,467, after a 9.6% move over the past 7 days, a modest 0.3% return over 30 days, and longer term returns of a 4.4% decline year to date, a 44.9% decline over 1 year, a 45.0% decline over 3 years, and a 58.1% decline over 5 years. Recent coverage around Sysmex has...

United Therapeutics (NasdaqGS:UTHR) has introduced Tresmi, a new soft mist inhaler platform aimed at reducing treatment side effects, including coughing. The company reported record annual revenue alongside this product launch. United Therapeutics also reported tangible progress in its organ manufacturing program focused on xenotransplantation. For investors watching United Therapeutics at a share price of $503.6, these updates add fresh detail to the story behind NasdaqGS:UTHR. The stock...

In February 2026, Viking® announced that bookings are open for several new 2027 itineraries on the Mississippi and Ohio rivers, including 8-, 15-, and 22-day destination-focused cruises between New Orleans, Memphis, Louisville, St. Louis, and St. Paul. By deepening its focus on culturally rich American river routes, spanning Civil War sites, musical heritage, and regional cuisine, Viking is broadening its appeal to experience-driven travelers seeking immersive itineraries. We’ll now examine...

In recent weeks, Northern Trust expanded its CLO middle-office services on the Omnium platform and broadened its dynamic currency hedging framework by adding Berenberg’s AI-based models, giving institutional clients more sophisticated compliance, waterfall calculation, and currency risk management options across major global markets. Together, these moves highlight Northern Trust’s emphasis on technology-enabled, fee-based services that aim to enhance operational efficiency and risk...

If you are wondering whether CorMedix stock is priced attractively or already baking in a lot of optimism, you are in the right place to unpack what the current share price might be implying. CorMedix recently closed at US$7.35, with returns of 3.8% over the past 7 days, a 5.2% decline over 30 days, a 39.6% decline year to date, and a 28.3% decline over 1 year, set against a 73.8% return over 3 years and 3.7% over 5 years. Recent coverage of CorMedix has focused on its position within the...